Lumibird launches product for dry eyes
This product integrates the C.SUITE offering, which covers dry eye diagnosis, treatment and patient education, and positions Lumibird Medical as a unique player in a market estimated to be worth $6.4 billion by 2024.
In the global dry eye market, the share dedicated to medical devices is growing fastest, with an estimated increase of over 20% by 2026", points out Delphine Southon, Product Manager for the dry eye range.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction